{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:14:07Z","timestamp":1788671647440,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304284"],"award-info":[{"award-number":["82304284"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22202178"],"award-info":[{"award-number":["22202178"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jare.2025.12.041","type":"journal-article","created":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T22:39:40Z","timestamp":1766961580000},"page":"1079-1104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Strategy and efficiency-redefined discovery of novel nanomolar tyrosinase inhibitors: AI de novo molecular generation\u00a0+\u00a0expert-guided structural optimization"],"prefix":"10.1016","volume":"87","author":[{"given":"Yinyan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keda","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3511-5794","authenticated-orcid":false,"given":"Renren","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jare.2025.12.041_b0005","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3390\/ijms19092668","article-title":"Clinical and biological characterization of skin pigmentation diversity and its consequences on UV impact","volume":"19","author":"Del Bino","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.jare.2025.12.041_b0010","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3390\/molecules25071537","article-title":"Photoprotection and skin pigmentation: Melanin-related molecules and some other new agents obtained from natural sources","volume":"25","author":"Solano","year":"2020","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.jare.2025.12.041_b0015","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.3390\/ijms22073727","article-title":"Skin pigmentation abnormalities and their possible relationship with skin aging","volume":"22","author":"Lee","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"15","key":"10.1016\/j.jare.2025.12.041_b0020","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.3390\/jcm13154312","article-title":"Prevention and treatment of skin pigmentation disorders","volume":"13","author":"Khamaysi","year":"2024","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.jare.2025.12.041_b0025","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.3390\/molecules28124839","article-title":"Skin pigmentation types, causes and treatment-a review","volume":"28","author":"Thawabteh","year":"2023","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.jare.2025.12.041_b0030","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/exd.13400","article-title":"Melanin pigmentation and melanoma","volume":"26","author":"Picardo","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jare.2025.12.041_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113744","article-title":"Recent advances in the design and discovery of synthetic tyrosinase inhibitors","volume":"224","author":"Li","year":"2021","journal-title":"Eur J Med Chem"},{"issue":"4","key":"10.1016\/j.jare.2025.12.041_b0040","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3390\/molecules30040788","article-title":"Small-molecule tyrosinase inhibitors for treatment of hyperpigmentation","volume":"30","author":"Ni","year":"2025","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.jare.2025.12.041_b0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/chem.201704410","article-title":"Structure and function of human tyrosinase and tyrosinase-related proteins","volume":"24","author":"Lai","year":"2017","journal-title":"Chem Eur J"},{"issue":"24","key":"10.1016\/j.jare.2025.12.041_b0050","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1021\/bi200395t","article-title":"Crystal structure of Agaricus bisporus mushroom tyrosinase: identity of the tetramer subunits and interaction with tropolone","volume":"50","author":"Ismaya","year":"2011","journal-title":"Biochemistry"},{"issue":"22","key":"10.1016\/j.jare.2025.12.041_b0055","doi-asserted-by":"crossref","first-page":"13428","DOI":"10.1021\/acs.jmedchem.0c00994","article-title":"Advances in the design of genuine human tyrosinase inhibitors for targeting melanogenesis and related pigmentations","volume":"63","author":"Roulier","year":"2020","journal-title":"J Med Chem"},{"issue":"15","key":"10.1016\/j.jare.2025.12.041_b0060","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.3390\/molecules28155762","article-title":"Tyrosinase inhibitors: a perspective","volume":"28","author":"Baber","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jare.2025.12.041_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111892","article-title":"Tyrosinase inhibitors as potential antibacterial agents","volume":"187","author":"Yuan","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jare.2025.12.041_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115672","article-title":"Catechol-mimicking transition-state analogues as non-oxidizable inhibitors of tyrosinases","volume":"259","author":"Beaumet","year":"2023","journal-title":"Eur J Med Chem"},{"issue":"23","key":"10.1016\/j.jare.2025.12.041_b0075","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400314","article-title":"Tyrosinase inhibition and antimelanogenic effects of resorcinol-containing compounds","volume":"19","author":"Beaumet","year":"2024","journal-title":"ChemMedChem"},{"issue":"3","key":"10.1016\/j.jare.2025.12.041_b0080","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s10637-025-01536-5","article-title":"Retrospective analysis of clinical features of pembrolizumab induced psoriasis","volume":"43","author":"Shu","year":"2025","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.jare.2025.12.041_b0085","first-page":"42","article-title":"Clinical features, treatment, and outcomes of nivolumab induced psoriasis","volume":"43","author":"Zhao","year":"2025","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.jare.2025.12.041_b0090","doi-asserted-by":"crossref","unstructured":"Cardoso R, Valente R, Souza da Costa CH, da S. Gon\u00e7alves Vianez JL, Santana da Costa K, de Molfetta FA, et al. Analysis of kojic acid derivatives as competitive inhibitors of tyrosinase: A molecular modeling approach. Molecules. 2021;26(10):2875.","DOI":"10.3390\/molecules26102875"},{"issue":"4","key":"10.1016\/j.jare.2025.12.041_b0095","first-page":"549","article-title":"Arbutin content and tyrosinase activity of bergenia extracts","volume":"12","author":"T\u016fmov\u00e1","year":"2017","journal-title":"Nat Prod Commun"},{"issue":"18","key":"10.1016\/j.jare.2025.12.041_b0100","doi-asserted-by":"crossref","first-page":"9990","DOI":"10.3390\/ijms25189990","article-title":"Pterostilbene, a dimethyl derivative of resveratrol, exerts cytotoxic effects on melanin-producing cells through metabolic activation by tyrosinase","volume":"25","author":"Tanaka","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.12.041_b0105","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3390\/ijms25020972","article-title":"6\u2019-O-caffeoylarbutin from Quezui Tea: a highly effective and safe tyrosinase inhibitor","volume":"25","author":"Xie","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jare.2025.12.041_b0110","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1080\/14756366.2018.1477776","article-title":"Kushenol a and 8-prenylkaempferol, tyrosinase inhibitors, derived from Sophora flavescens","volume":"33","author":"Kim","year":"2018","journal-title":"J Enzym Inhib Med Chem"},{"key":"10.1016\/j.jare.2025.12.041_b0115","article-title":"Anti-melanogenic properties of greek plants. a novel depigmenting agent from Morus alba Wood","volume":"22(4):514","author":"Chaita","year":"2017","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.jare.2025.12.041_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103843","article-title":"Valorization of biomass polyphenols as potential tyrosinase inhibitors","volume":"29","author":"Pham","year":"2024","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jare.2025.12.041_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112480","article-title":"Kojic acid-natural product conjugates as mushroom tyrosinase inhibitors","volume":"201","author":"Ashooriha","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jare.2025.12.041_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104979","article-title":"Anti-melanogenesis and anti-tyrosinase properties of aryl-substituted acetamides of phenoxy methyl triazole conjugated with thiosemicarbazide: design, synthesis and biological evaluations","volume":"114","author":"Hosseinpoor","year":"2021","journal-title":"Bioorg Chem"},{"issue":"39","key":"10.1016\/j.jare.2025.12.041_b0135","doi-asserted-by":"crossref","first-page":"28524","DOI":"10.1039\/D4RA05015K","article-title":"Design, synthesis, and in vitro and in silico study of 1-benzyl-indole hybrid thiosemicarbazones as competitive tyrosinase inhibitors","volume":"14","author":"Batool","year":"2024","journal-title":"RSC Adv"},{"issue":"37","key":"10.1016\/j.jare.2025.12.041_b0140","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1039\/D4OB01225A","article-title":"Exploring 2-mercapto-N-arylacetamide analogs as promising anti-melanogenic agents: in vitro and in vivo evaluation","volume":"22","author":"Jung","year":"2024","journal-title":"Org Biomo Chem"},{"key":"10.1016\/j.jare.2025.12.041_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114147","article-title":"Cinnamic acid derivatives linked to arylpiperazines as novel potent inhibitors of tyrosinase activity and melanin synthesis","volume":"231","author":"Romagnoli","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jare.2025.12.041_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116136","article-title":"In vitro and in vivo anti-pigmentation effects of 2-mercaptobenzimidazoles as nanomolar tyrosinase inhibitors on mammalian cells and zebrafish embryos: Preparation of pigment-free zebrafish embryos","volume":"266","author":"Yoon","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jare.2025.12.041_b0155","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.molstruc.2019.02.071","article-title":"3D-QSAR and molecular docking studies of aminopyrimidine derivatives as novel three-targeted Lck\/Src\/KDR inhibitors","volume":"1185","author":"Xie","year":"2019","journal-title":"J Mol Struct"},{"key":"10.1016\/j.jare.2025.12.041_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129742","article-title":"Discovery of novel nucleoside derivatives as selective lysine acetyltransferase p300 inhibitors for cancer therapy","volume":"104","author":"Dai","year":"2024","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jare.2025.12.041_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138331","article-title":"Synthesis, bioactivity evaluation and theoretical study of nicotinamide derivatives containing diphenyl ether fragments as potential succinate dehydrogenase inhibitors","volume":"1308","author":"Yan","year":"2024","journal-title":"J Mol Struct"},{"issue":"12","key":"10.1016\/j.jare.2025.12.041_b0170","doi-asserted-by":"crossref","first-page":"10057","DOI":"10.1021\/acs.jmedchem.4c00184","article-title":"Synthetically feasible de novo molecular design of leads based on a reinforcement learning model: AI-assisted discovery of an anti-IBD lead targeting CXCR4","volume":"67","author":"Jiang","year":"2024","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.jare.2025.12.041_b0175","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drudis.2020.10.010","article-title":"Artificial intelligence in drug discovery and development","volume":"26","author":"Paul","year":"2021","journal-title":"Drug Discov Today"},{"issue":"3","key":"10.1016\/j.jare.2025.12.041_b0180","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s11030-021-10217-3","article-title":"Artificial intelligence to deep learning: machine intelligence approach for drug discovery","volume":"25","author":"Gupta","year":"2021","journal-title":"Mol Divers"},{"key":"10.1016\/j.jare.2025.12.041_b0185","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.omtn.2023.02.019","article-title":"Artificial intelligence for drug discovery: resources, methods, and applications","volume":"31","author":"Chen","year":"2023","journal-title":"Mol Ther Nucl Acids"},{"issue":"6","key":"10.1016\/j.jare.2025.12.041_b0190","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4155\/fmc-2018-0358","article-title":"Deep learning for molecular generation","volume":"11","author":"Xu","year":"2019","journal-title":"Future Med Chem"},{"issue":"2","key":"10.1016\/j.jare.2025.12.041_b0195","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1021\/acs.accounts.0c00699","article-title":"Applications of deep learning in molecule generation and molecular property prediction","volume":"54","author":"Walters","year":"2020","journal-title":"Acc Chem Res"},{"issue":"1","key":"10.1016\/j.jare.2025.12.041_b0200","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1038\/s41467-023-41454-9","article-title":"A pharmacophore-guided deep learning approach for bioactive molecular generation","volume":"14","author":"Zhu","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jare.2025.12.041_b0205","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.1038\/s41467-024-49620-3","article-title":"Deep representation learning of chemical-induced transcriptional profile for phenotype-based drug discovery","volume":"15","author":"Tong","year":"2024","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.jare.2025.12.041_b0210","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.drudis.2021.05.019","article-title":"De novo molecular design and generative models","volume":"26","author":"Meyers","year":"2021","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jare.2025.12.041_b0215","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1021\/acs.jcim.3c01496","article-title":"Deep generative models in de novo drug molecule generation","volume":"64","author":"Pang","year":"2024","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.jare.2025.12.041_b0220","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aap7885","article-title":"Deep reinforcement learning for de novo drug design","volume":"4","author":"Popova","year":"2018","journal-title":"Sci Adv"},{"issue":"18","key":"10.1016\/j.jare.2025.12.041_b0225","doi-asserted-by":"crossref","first-page":"10520","DOI":"10.1021\/acs.chemrev.8b00728","article-title":"Concepts of artificial intelligence for computer-assisted drug discovery","volume":"119","author":"Yang","year":"2019","journal-title":"Chem Rev"},{"issue":"8","key":"10.1016\/j.jare.2025.12.041_b0230","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrd1799","article-title":"Computer-based de novo design of drug-like molecules","volume":"4","author":"Schneider","year":"2005","journal-title":"Nat Rev Drug Discov"},{"issue":"6\u20137","key":"10.1016\/j.jare.2025.12.041_b0235","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/minf.201400034","article-title":"Future de novo drug design","volume":"33","author":"Schneider","year":"2014","journal-title":"Mol Inform"},{"issue":"12","key":"10.1016\/j.jare.2025.12.041_b0240","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1021\/acscentsci.3c00572","article-title":"Geometric deep learning for structure-based ligand design","volume":"9","author":"Powers","year":"2023","journal-title":"ACS Cent Sci"},{"issue":"9","key":"10.1016\/j.jare.2025.12.041_b0245","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s42256-023-00712-7","article-title":"ResGen is a pocket-aware 3D molecular generation model based on parallel multiscale modelling","volume":"5","author":"Zhang","year":"2023","journal-title":"Nat Mach Intell"},{"issue":"1","key":"10.1016\/j.jare.2025.12.041_b0250","doi-asserted-by":"crossref","first-page":"7928","DOI":"10.1038\/s41467-025-63245-0","article-title":"Target-aware 3D molecular generation based on guided equivariant diffusion","volume":"16","author":"Hu","year":"2025","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.jare.2025.12.041_b0255","article-title":"Molecular generative model via retrosynthetically prepared chemical building block assembly","volume":"10","author":"Seo","year":"2023","journal-title":"Adv Sci"},{"key":"10.1016\/j.jare.2025.12.041_b0260","unstructured":"Li Y, Pei J, Lai L. Synthesis-driven design of 3D molecules for structure-based drug discovery using geometric transformers. 2022:arXiv preprint arXiv: 2301.00167. https:\/\/doi.org\/00110.48550\/arXiv.02301.00167."},{"key":"10.1016\/j.jare.2025.12.041_b0265","unstructured":"Gao W, Mercado R, Coley CW. Amortized tree generation for bottom-up synthesis planning and synthesizable molecular design. 2021:arXiv preprint arXiv: 2110.06389. https:\/\/doi.org\/06310.48550\/arXiv.02110.06389."},{"issue":"2","key":"10.1016\/j.jare.2025.12.041_b0270","article-title":"DOGS: Reaction-driven de novo design of bioactive compounds","volume":"8","author":"Briggs","year":"2012","journal-title":"PLoS Comput Biol"},{"issue":"51","key":"10.1016\/j.jare.2025.12.041_b0275","doi-asserted-by":"crossref","first-page":"32984","DOI":"10.1021\/acsomega.0c04153","article-title":"Molecular design in synthetically accessible chemical space via deep reinforcement learning","volume":"5","author":"Horwood","year":"2020","journal-title":"ACS Omega"},{"issue":"7","key":"10.1016\/j.jare.2025.12.041_b0280","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1007\/s10994-024-06519-w","article-title":"Utilizing reinforcement learning for de novo drug design","volume":"113","author":"Gummesson Svensson","year":"2024","journal-title":"Mach Learn"},{"key":"10.1016\/j.jare.2025.12.041_b0285","first-page":"15","article-title":"Soft Actor-Critic: off-policy maximum entropy deep reinforcement learning with a stochastic actor","volume":"8","author":"Haarnoja","year":"2018","journal-title":"arXiv"},{"key":"10.1016\/j.jare.2025.12.041_b0290","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.ins.2020.08.101","article-title":"A reinforcement learning approach for dynamic multi-objective optimization","volume":"546","author":"Zou","year":"2021","journal-title":"Inf Sci"},{"issue":"9","key":"10.1016\/j.jare.2025.12.041_b0295","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1021\/acs.jmedchem.4c00091","article-title":"Artificial intelligence-assisted optimization of antipigmentation tyrosinase inhibitors: De novo molecular generation based on a low activity lead compound","volume":"67","author":"Cai","year":"2024","journal-title":"J Med Chem"},{"issue":"18","key":"10.1016\/j.jare.2025.12.041_b0300","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/cmdc.202000125","article-title":"4-Fluorobenzylpiperazine-containing derivatives as efficient inhibitors of mushroom tyrosinase","volume":"15","author":"Vittorio","year":"2020","journal-title":"ChemMedChem"},{"issue":"15","key":"10.1016\/j.jare.2025.12.041_b0305","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1080\/10408398.2021.1871724","article-title":"A systematic review of synthetic tyrosinase inhibitors and their structure-activity relationship","volume":"62","author":"Peng","year":"2021","journal-title":"Crit Rev Food Sci"},{"key":"10.1016\/j.jare.2025.12.041_b0310","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejmech.2018.10.025","article-title":"Synthesis of cinnamic amide derivatives and their anti-melanogenic effect in \u03b1-MSH-stimulated B16F10 melanoma cells","volume":"161","author":"Ullah","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"5","key":"10.1016\/j.jare.2025.12.041_b0315","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1039\/C8MD00099A","article-title":"Design, synthesis and evaluation of cinnamic acid ester derivatives as mushroom tyrosinase inhibitors","volume":"9","author":"Sheng","year":"2018","journal-title":"MedChemComm"},{"key":"10.1016\/j.jare.2025.12.041_b0320","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ejmech.2019.06.019","article-title":"Exploiting the 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors as anti-melanogenic agents: Design, synthesis, structural insights and biological profile","volume":"178","author":"Ielo","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"9","key":"10.1016\/j.jare.2025.12.041_b0325","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1021\/acs.jmedchem.7b01745","article-title":"Targeting tyrosinase: Development and structural insights of novel inhibitors bearing arylpiperidine and arylpiperazine fragments","volume":"61","author":"Ferro","year":"2018","journal-title":"J Med Chem"},{"issue":"7","key":"10.1016\/j.jare.2025.12.041_b0330","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1021\/acs.jmedchem.3c00012","article-title":"Design, synthesis, and biological evaluation of novel hybrids containing dihydrochalcone as tyrosinase inhibitors to treat skin hyperpigmentation","volume":"66","author":"Xue","year":"2023","journal-title":"J Med Chem"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225010318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225010318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:27:30Z","timestamp":1788668850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123225010318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":66,"alternative-id":["S2090123225010318"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2025.12.041","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategy and efficiency-redefined discovery of novel nanomolar tyrosinase inhibitors: AI de novo molecular generation\u00a0+\u00a0expert-guided structural optimization","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2025.12.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}